drugset / Trial / NCT04544709

Intradiscal Platelet Rich Plasma

NCT04544709

Phase 4 Terminated 3 enrolled University of Utah
NaSingle-groupOpen-labelTreatment

Summary

To assess changes in pain and function in patients with discogenic low back pain after a standard of care intradiscal injection of Platelet-Rich Plasma (PRP).

Timeline

Start
2019-02-14
Primary completion
2022-07-29
Completion
2022-07-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other